Angeles Investment Advisors’s CONMED CNMD Stock Holding History

Angeles Investment Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,949	Closed	-$255K	–	226
2021 Q3	$255K	Buy	+1,949	New	+$255K	0.01%	188

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Angeles Investment Advisors's CNMD Position: Q4 2021 in Review

Angeles Investment Advisors sold out of CONMED (CNMD) in Q4 2021, closing a stake of 1,949 shares — an estimated $255K sold.

Angeles Investment Advisors first reported a position in CNMD in Q3 2021 and held it in 1 quarter. The position peaked at $255K in Q3 2021. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2021.

Angeles Investment Advisors reported no remaining CONMED position as of Q4 2021 after selling out during the quarter.
Angeles Investment Advisors sold 1,949 CONMED shares in Q4 2021, an estimated $255K.
Angeles Investment Advisors first reported a position in CONMED in Q3 2021 and held it in 1 quarter.
Angeles Investment Advisors's CONMED position peaked at $255K in Q3 2021.
265 funds tracked by Wall St. Rank held CONMED as of Q4 2021.

Based on Angeles Investment Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.